Summit Therapeutics Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Summit Therapeutics Inc. (SMMT) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $709.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-07-23
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $16.24M.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $815.00K.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $17.06M, a 304.55% increase from fiscal 2024.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $4.22M, a 0.68% decline from fiscal 2023.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $4.25M, a 48.43% increase from fiscal 2022.
- Summit Therapeutics Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $2.86M, a 15.61% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 11 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $709.00K 10-Q · filed 2026-07-23 | ||||
| 2025-12-31 | $16.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $17.06M derived: sum of 2 quarters · filed 2026-02-23 | $17.06M derived: sum of 3 quarters · filed 2026-07-23 | $17.06M 10-K · filed 2026-02-23 | |
| 2025-09-30 | $815.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | $815.00K derived: sum of 2 quarters · filed 2026-07-23 | $815.00K 10-Q · filed 2025-10-20 | $815.00K derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $0.00 10-Q · filed 2026-07-23 | $0.00 derived: sum of 3 quarters · filed 2026-07-23 | $0.00 derived: sum of 4 quarters · filed 2026-07-23 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-01 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $0.00 derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $0.00 derived: sum of 3 quarters · filed 2026-02-23 | $4.22M 10-K · filed 2026-02-23 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-20 | $0.00 derived: sum of 2 quarters · filed 2025-10-20 | $4.22M 10-Q · filed 2025-10-20 | $4.22M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $4.22M 10-Q · filed 2025-08-11 | $4.22M derived: sum of 3 quarters · filed 2026-02-23 | $4.22M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2024-03-31 | $4.22M 10-Q · filed 2025-05-01 | $4.22M derived: sum of 2 quarters · filed 2026-02-23 | $4.22M derived: sum of 3 quarters · filed 2026-02-23 | $8.46M derived: sum of 4 quarters · filed 2026-02-23 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $0.00 derived: sum of 2 quarters · filed 2026-02-23 | $4.25M derived: sum of 3 quarters · filed 2026-02-23 | $4.25M 10-K · filed 2026-02-23 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $4.25M derived: sum of 2 quarters · filed 2024-10-30 | $4.25M 10-Q · filed 2024-10-30 | $4.35M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-06-30 | $4.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $4.25M 10-Q · filed 2024-08-06 | $4.35M derived: sum of 3 quarters · filed 2025-02-24 | $7.11M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-01 | $104.00K derived: sum of 2 quarters · filed 2025-02-24 | $2.86M derived: sum of 3 quarters · filed 2025-02-24 | $2.86M derived: sum of 4 quarters · filed 2025-02-24 | |
| 2022-12-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $2.86M derived: sum of 2 quarters · filed 2025-02-24 | $2.86M derived: sum of 3 quarters · filed 2025-02-24 | $2.86M 10-K · filed 2025-02-24 | |
| 2022-09-30 | $2.76M 10-Q · filed 2022-11-09 | $2.76M derived: sum of 2 quarters · filed 2023-08-09 | $2.76M 10-Q · filed 2023-11-07 | $4.02M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $1.26M derived: sum of 3 quarters · filed 2023-08-09 | $1.26M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-11 | $1.26M derived: sum of 2 quarters · filed 2023-03-09 | $1.26M derived: sum of 3 quarters · filed 2023-03-09 | $2.30M derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $1.26M derived: sum of 2 quarters · filed 2023-03-09 | $2.30M derived: sum of 3 quarters · filed 2023-03-09 | $3.39M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $1.04M derived: sum of 2 quarters · filed 2022-11-09 | $2.12M 10-Q · filed 2022-11-09 | $2.12M derived: sum of 4 quarters · filed 2022-12-21 | |
| 2021-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.12M 10-Q · filed 2022-08-11 | $2.12M derived: sum of 3 quarters · filed 2022-12-21 | $2.12M derived: sum of 4 quarters · filed 2022-12-21 | |
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-11 | $1.08M derived: sum of 2 quarters · filed 2022-12-21 | $1.08M derived: sum of 3 quarters · filed 2022-12-21 | ||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-12-21 | $0.00 derived: sum of 2 quarters · filed 2022-12-21 | $0.00 10-K/A · filed 2022-12-21 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | ||||
| 2019-12-31 | $0.00 8-K · filed 2020-09-29 | ||||
| 2019-01-31 | $0.00 8-K · filed 2020-09-29 | ||||
| 2018-01-31 | $2.21M 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |